Armie Margaret Lee

Armie Margaret Lee is a reporter covering private equity. Previously, she was at InvestmentWires, an online media company that focuses on the mutual fund and 401(k) industries. She has also covered real estate and banking for Miami Today and technology for Manila Times in the Philippines.

Recent Articles By The Author

Teva Notches Win With FDA Approval of Generic EpiPen

Teva Notches Win With FDA Approval of Generic EpiPen

The regulatory agency has authorized the sale of the drugmaker's generic version of Mylan's EpiPen.

Loncar China BioPharma ETF Makes Nasdaq Debut

Loncar China BioPharma ETF Makes Nasdaq Debut

The launch comes as China's biotech industry is undergoing a transformation, index developer Brad Loncar noted in an interview.

Buffett Ups Stake in Teva

Buffett Ups Stake in Teva

Warren Buffett's Berkshire Hathaway increases its stake in the drugmaker to 43.2 million shares from 40.5 million shares at the end of March.

EpiPen Maker Mylan to Explore Options, Shares Sink

EpiPen Maker Mylan to Explore Options, Shares Sink

The drugmaker 's board said the U.S. public markets 'continue to underappreciate and undervalue' the company's diversified business.

Eli Lilly Shares Climb on Earnings Beat

Eli Lilly Shares Climb on Earnings Beat

The Indianapolis-based pharmaceutical giant unveils second-quarter results that surpass analysts' top- and bottom-line estimates.

3 Things to Watch When Biogen Reports Second-Quarter Results

3 Things to Watch When Biogen Reports Second-Quarter Results

The Cambridge, Mass.-based biotech is scheduled to unveil its second-quarter results before the market open on July 24.

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

GSK Shares Climb as Board Is Said to Mull Breakup of Pharma Giant

The pharmaceutical giant's American depository receipts jumped on the heels of a report that the company's chairman is mulling a breakup of the firm.

Three Key Takeaways From Healthcare Earnings Season

Three Key Takeaways From Healthcare Earnings Season

Drug pricing remains front and center as healthcare companies start reporting quarterly results.

Abbott Shares Rise on Second-Quarter Beat, Increased Guidance

Abbott Shares Rise on Second-Quarter Beat, Increased Guidance

The Abbott Park, Ill., healthcare company beats top- and bottom-line estimates and raises its full-year outlook for earnings.

Abbott's Capital Flexibility in Focus Ahead of Earnings Release

Abbott's Capital Flexibility in Focus Ahead of Earnings Release

In April, CEO Miles White said the healthcare company had paid down $6 billion of debt this year and expected to pay down another $2 billion by the end of 2018.